Low‐dose colchicine vs NSAIDs
Number of participants reporting an adverse event · acute gout
Low‐dose colchicine showed no clear difference in total number of participants reporting adverse events compared with NSAIDs (low certainty).
1 finding from 1 review
- RR 1.07 [0.88, 1.29]1 study · 399 participantsLow